Nyxoah Announces U.S. FDA Breakthrough Device Designation Gr

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse | Comunicados | Edición USA